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Abstract
Background: Spinal cord injury is a major cause of disability that has no clinically accepted treatment. Functional decline
following spinal cord injury is caused by mechanical damage, secondary cell death, reactive gliosis and a poor regenerative
capacity of damaged axons. Wnt proteins are a family of secreted glycoproteins that play key roles in different
developmental processes although little is known of the expression patterns and functions of Wnts in the adult central
nervous system in normal or diseased states.
Findings: Using qRT-PCR analysis, we demonstrate that mRNA encoding most Wnt ligands and soluble inhibitors are
constitutively expressed in the healthy adult spinal cord. Strikingly, contusion spinal cord injury induced a time-dependent
increase in Wnt mRNA expression from 6 hours until 28 days post-injury, and a narrow peak in the expression of soluble Wnt
inhibitors between 1 and 3 days post-injury. These results are consistent with the increase in the migration shift, from day 1
to 7, of the intracellular Wnt signalling component, Dishevelled-3. Moreover, after an initial decrease by 1 day, we also found
an increase in phosphorylation of the Wnt co-receptor, low-density lipoprotein receptor-related protein 6, and an increase in
active b-catenin protein, both of which suffer a dramatic change, from a homogeneous expression pattern in the grey
matter to a disorganized injury-induced pattern.
Conclusions: Our results suggest a role for Wnts in spinal cord homeostasis and injury. We demonstrate that after injury Wnt
signalling is activated via the Wnt/b-catenin and possibly other pathways. These findings provide an important foundation
to further address the function of individual Wnt proteins in vivo and the pathophysiology of spinal cord injury.
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Introduction
Spinal cord injury (SCI) is a major cause of disability with no
clinically accepted treatment [1]. The functional impairment
following SCI is produced by multi-factorial processes as a result of
primary mechanical damage, secondary cell death, reactive gliosis
and the poor capacity to regenerate damaged axons. Typically, the
epicentre of the SCI is characterized by necrotic neural death,
while secondary tissue damage is also evident in the penumbra
zone, where processes such as ischemia, hypoxia, excitotoxicity,
free radical formation, protease release and inflammation
contribute to the expansion of segmental loss of function. Another
serious detrimental effect of SCI is the massive death of
oligodendrocytes at a distance from the epicentre of the insult,
leading to demyelination and deteriorated axon conduction. The
final outcome is a pathohistological lesion that is far larger than the
initial mechanical wound, consisting of a cyst cavity surrounded by
a glial scar that inhibits axon growth [2–4].
The Wnt family of proteins plays key roles during the
development of the nervous system, influencing cell proliferation
and patterning, cell polarity and motility, axonal guidance,
neuronal survival and connectivity, and cell-cell adhesion [5,6].
This wide range of effects is possible because the specific responses
elicited in target cells are dependent on the spatiotemporal
distribution of Wnt ligands, modulators and receptors [7–11].
To date, 19 Wnt ligands and 10 Frizzled (Fz) receptors have
been identified, which activate at least three different signalling
pathways: the canonical or Wnt/b-catenin pathway; and the non-
canonical Planar Cell Polarity (PCP, Wnt-JNK) and Wnt-Ca
2+
pathways. Activation of the canonical pathway relies on the
interaction of the Fz receptor with the low-density lipoprotein
receptor-related protein 5/6 (LRP5/6), which leads to b-catenin
stabilization in the cytosol, and ultimately in the nucleus, via
Dishevelled (Dvl). Nuclear b-catenin combines with T-cell factor/
lymphoid enhancer factor (TCF/LEF) family of DNA-binding
proteins to activate the expression of genes that are mainly linked
to cell proliferation [12-14]. By contrast, non-canonical pathways
are activated by either LRP-independent Fz receptors or by a set
of non-conventional receptors, such as Ryk and Receptor Tyrosine
Kinase-Like Orphan Receptor (ROR-1/2), which have mainly
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[15-17]. Finally, activation or inhibition of Wnt signalling is
further modulated by co-receptors, such as Kremen (Krm1/2),
and antagonists, such as the Wnt inhibitory factor 1 (Wif1),
Dickkopf (Dkk) and secreted Frizzled-Related Proteins (sFRPs)
[18,19].
Although even the earliest reports suggested that Wnt
expression in the nervous system may be prolonged into
adulthood [20,21], little is known about the expression or function
of Wnt at these stages. Functional studies in the adult have been
hampered by the labile nature of Wnt proteins, the embryonic
lethality of mutants and by a lack of selective pharmacological
tools [9]. Otherwise, the literature provides ample evidence
implicating Wnt signalling pathways in adult CNS homeostasis
and disease [13,22–35], including SCI [32,33,36–41]. In this way,
experimental modulation of Wnt-dependent pathways has pro-
duced promising results in different neuropathological situations
[22,23,25,29], such as in stroke, where Dkk1 is expressed by
neurons with pro-apoptotic effects, a process that can be rescued
by lithium [42]. Furthermore, Glycogen Synthase Kinase-3b
(GSK3-b) inhibition [36], lithium [36,43] or Wnt3a [41], all of
which activate Wnt/b-catenin signalling, exert neuroprotective
effects in SCI.
However, to our knowledge, the expression of Wnts has been
reported as undetectable by in situ hybridization (ISH) in the adult
spinal cord of mice, while after SCI only Wnt1, Wnt4 and Wnt5a
together with Frizzled-1 and Ryk receptors were transiently induced
[32], with no effect on ß-catenin mediated transcription [35]. On
the other hand, in rats, the only Wnt protein shown to be
expressed after SCI is Wnt5a, which is expressed by astrocytes
from the glial scar and inhibits corticospinal regeneration through
non-canonical Ryk activation [33].
Therefore, to investigate the role of the Wnt family of proteins
in the adult spinal cord, we decided to profile by quantitative
Real Time-PCR (qRT-PCR) the temporal pattern of mRNA
expression for all Wnt ligands and inhibitors, followed by
Western-blot and immunohistochemistry analysis of key members
of the canonical pathway, in both non-injured and a moderate
contusion model of SCI in rats. In agreement with previous
indirect findings [22,29,44,45], our results demonstrate that most
Wnt ligands and inhibitors are constitutively expressed in the
non-injured adult spinal cord, with activation of at least the
canonical pathway in the grey matter. After injury, this pattern
of expression was dramatically altered with significant activa-
tion of the canonical pathway in a large proportion of
cells around the epicentre of the wound. The reasons for the
difference between our results and previous studies in mice might
be the higher sensitivity of qRT-PCR versus the ISH technique,
but also a different pattern of Wnt expression between mice and
rats. Hence, Wnts would appear to participate in the SCI
pathophysiology.
Materials and Methods
Animals
Adult female Wistar rats, aged 10–12 weeks and weighing 200–
220 grams were used throughout the study. Animals were obtained
from Harlan (Barcelona, Spain) and housed in climate controlled
quarters with a 12 hour light cycle. Handling was carried out
according to European Union and NIH guidelines for animal
experimentation in order to minimize suffering and the number of
animals used. All the experimental protocols were approved by the
Bioethics Committee of The National Hospital of Paraplegics
(Permit numbers 51/2009 and 45/2008).
Surgical procedure and experimental design
Sterile surgical techniques and methods were used throughout
this study in a designated room. Briefly, rats were anesthetized
with intraperitoneal injections of pentobarbital (40 mg/kg) and
xylazine (10 mg/kg). Laminectomy was performed at the level of
T8 via a controlled 200-kilodyne contusion injury using an Infinite
Horizon Impactor (Precision Systems and Instrumentation LLC),
and the overlying muscle and skin layers were sutured. After
surgery, rats were allowed to recover on a warmed blanket with
access to water and food, and they received daily subcutaneous
injections of saline solution containing enrofloxacine (2.5 mg/kg)
and buprenorphine (0.03 mg/kg) for the following 5 and 2 days,
respectively. Post-operative care also included manual bladder
emptying twice daily until recovery of voiding control was
achieved, and inspection for signs of infection, dehydration or
autophagia.
The Open-Field Locomotor Basso-Beattie-Bresnahan (BBB)
scale was applied by two examiners blind to the treatments to
determine severity and reproducibility of injury on days 1, 3, 7, 14
and 28 post-injury (dpi) [46]. In order to establish a homogeneous
group in which expression levels were strictly due to temporal
changes after injury, animals with a functional score 0–3 the day
after surgery (at 24 hours) were excluded from the study. In the
entire study, only one animal from the 28 dpi group was excluded.
A total of 21 animals were randomly distributed between each of
the following 7 groups for qRT-PCR analysis (n=3 per group):
Non-Injured Control (C), 6 hours post-injury (hpi), and 1, 3, 7, 14
and 28 dpi. For histological and Western blot studies 30 animals
were randomly distributed into each of the following groups (n=3
per group and technique): C, 1, 7, 14 and 28 dpi.
RNA isolation and qRT-PCR analysis
At each of the time-points chosen for study, animals were
terminally anesthetized with pentobarbital (40 mg/kg) and
perfused intracardially with heparinized saline (150 ml) to remove
blood from the tissue. Total RNA was isolated with the RNeasy
Lipid Mini Kit (Qiagen) from a 1 cm long fragment of the spinal
cord containing the wound epicentre, according to the manufac-
turer’s instructions. Complementary DNA (cDNA) was synthe-
sized from DNase-treated RNA (3 mg) as described previously
[47]. For relative quantification, each gene of interest was first
subjected to a serial dilution assay to determine the optimum
detection range of Ct values, with a Ct threshold of 35 for
undetectable levels of expression. Relative quantitation of all 19
Wnt ligands, the co-receptors of the b-catenin signalling cascade
(LRP5/6), the soluble Wnt signalling inhibitors (sFRP-1/5, Wif1,
Dkk-1/3) and the intracellular canonical Wnt signalling effectors
(GSK-3b and b-catenin) was performed using 10 ng of reverse-
transcribed total RNA, 20 pmol/ml of both sense and antisense
primers, and the Fast SYBR Green PCR Master Mix (Applied
Biosystems) in a final reaction volume of 20 ml. The reactions were
run on an ABI PRISM 7900 Fast Sequence Detection System
instrument and software (Applied Biosystem) according to the
manufacturer’s protocol.
To standardize the amount of sample cDNA added to the
reaction, amplification of endogenous control 18S rRNA (primers
sequence obtained from [48]) were included in a separate well as a
real-time reporter. In all cases, primers were designed using
Primer Express software and validated before their use on
embryonic cDNA. Primers not specified in the attached table
(Table 1) had previously been validated [47]. At the end of each
run, melting curve profiles were performed to confirm amplifica-
tion of specific transcripts. Relative quantification for each gene
was performed by the DDCt method [49] and reported as mean 6
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Western blotting
Spinal cords from animals intracardially perfused with hepa-
rinized saline were rapidly dissected and a 1 cm long fragment
containing the injury epicentre was homogenized in RIPA buffer
(Sigma-Aldrich) containing a proteinase inhibitor cocktail (Roche).
Denatured protein samples (100 mg) from each group (C, 1, 7, 14
and 28 dpi: n=3 per group) were resolved on a 10% SDS-PAGE
gel (BioRad) and transferred to PVDF membranes (Millipore).
Membranes were blocked for 1 hour in 5% non-fat dried milk
containing TBS-T (0.1 M Tris-HCl [pH 7.4], 0.15 M NaCl and
0.1% Tween 20) and probed overnight at 4uC with a primary
mouse Dvl-3 antibody (1:500; Santa Cruz Biotechnology Inc.).
After washing, the membranes were incubated for 1 hour at room
temperature (RT) with a Horse Radish Peroxidase (HRP)-
conjugated anti-mouse secondary antibody (1:5000; Amersham),
and the resulting antibody binding was visualized by bathing for 2
minutes in the ECL solution (SuperSignal West Pico Chemilumi-
nescent Substrate, Thermo Scientific) and exposing to hyperfilm
(Amersham) for 1–10 minutes. The antibodies were subsequently
stripped from the membranes by incubating them for 5 minutes in
buffer (0.1 M Glycine [pH 2.9]), and after washing in TBS-T for
15 minutes they were re-probed with a mouse anti-GAPDH
antibody (1:10.000; Abcam) as a loading control.
Histology
As described above, 3 animals from each experimental group
(C, 1, 7, 14 and 28 dpi) were perfused intracardially with a
heparinized saline solution followed by 4% paraformaldehyde,
and their spinal cords post-fixed for 4 hours in the same fixative.
The spinal cords were then cryoprotected by immersion in 30%
sucrose for 48 hours, embedded in Neg-50 frozen medium
(Richard-Allan Scientific) and stored at 220uC. From each spinal
cord, 30 mm thick parallel cryostat sections were obtained
(Microm) from a 3-cm long fragment containing the wound
epicentre, which were mounted on 33 serial slides and stored at
220uC.
To generate a histological time-course of phosphorylated-LRP6
(p-LRP6) and active b-catenin expression in the lesioned spinal
cord, a set of parallel sections from each animal was processed by
immunohistochemistry. Briefly, endogenous peroxidase activity
was inactivated in the sections by incubation with 2% H2O2 in a
70% methanol solution at RT for 10 minutes, and they were then
blocked for 1 hour at RT in blocking buffer (BB) containing 10%
Fetal Bovine Serum (FBS), 0.3% Bovine Serum Albumin (BSA)
and 0.3% Triton X-100 in TBS. The sections were then incubated
overnight at 4uC with the primary rabbit anti-p-LRP6 (1:100; Cell
Signaling) or rabbit anti-active b-catenin (1:500; Millipore)
antibodies in BB, plus 1 hour at RT. Antibody binding was
visualized by sequential incubations with a biotinylated anti-rabbit
secondary antibody (1:500; VectorLabs) and HRP-linked strepta-
vidin (1:500; Perkin Elmer), and with the ‘‘Nova Red Kit’’
(VectorLabs) according to the manufacturers instructions. The
sections were finally dehydrated in graded ethanol, cleared with
xylene and coverslipped with DPX (Panreac).
Statistical analysis
Statistical comparisons were examined by one-way ANOVA
(GraphPad Prism 4.0 software), followed by a Tukey post hoc test
to determine individual differences between means. P values lower
than 0.05 were considered as statistically significant.
Results
Wnt ligands expression is prolonged in the adult spinal
cord and is modulated by injury
In order to investigate the role of the Wnt family of proteins in
the adult spinal cord, we examined by qRT-PCR the temporal
pattern of mRNA expression for all Wnt ligands in both non-
injured rats and in SCI rats up to 28 days after moderate spinal
cord contusion. Of the 19 Wnt ligands already described in rats,
we found that most were expressed in non-injured adult spinal
Table 1. List of qRT-PCR primers.
Gene name Forward primer Reverse primer Acc no.
b-catenin 59-GCCAAGTGGGTGGCATAGA-39 59-TCCCTGTCACCAGCACGAA-39 NM_053357.2
Dkk-1 59-CTGTCTGCCTCCGATCATCA-39 59-CAGAAATGTCTTGCACAACACA-39 NM_001106350.1
Dkk-2 59-GCTCGCGGGCCAAAC-39 59-CAACTCCATCAAGTCC-39 NM_001106472.1
Dkk-3 59-CAGCTGTGACATCCAGACAGAAG-39 59-GCACCTGAAACTGTCATCTGAGA-39 NM_138519.1
Dkk-4 59-AGGCCTCTGTGGGCAACTT-39 59-CTAAGGCTGGGCTGCTGAGT-39 NM_001109332.1
GSK-3b 59-TCTGGCCACCATCCTTATCC-39 59-TTGCAGGCGGTGAAGCA-39 NM_032080.1
sFRP-1 59-CTGCCACCAGCTGGACAAC-39 59-ACCTTGCGCCCCATGA-39 XM_224987.4
sFRP-2 59-CGTGAAACGGTGGCAGAAG-39 59-CGGATGCTGCGGGAGAT-39 NM_001100700.1
sFRP-3 59-CTACCCTGGAACATGACCAAGAT-39 59-TGGCGTTAGCCTGGGTACTG-39 NM_001100527.1
TCF-1 59-GCTGCTTCAGGGCTAAGATTGT-39 59-TGTGACCTTGGCATGAGTTACG-39 NM_012669.1
Wnt6 5 `-GCGGTCACTCAGGCCTGTT-39 59-GGGTGCCTGACAACCACACT-39 NM_001108226.1
Wnt8 59-CCTGGGAGCGGTGGAACT-39 59-CCTGGTGTGGGTTGAAAACTG-39 NM_001106155.1
Wnt10b 5 -CCTCAAGCGCGGTTTCC-39 59-CAGCAGCCAGCATGGAGAA-39 NM_001108111.1
Wnt15 59-CACCCATGTGGGCATCAA-39 59-CCATGACACTTGCAGGTTGTTC-39 NM_001107055.1
Wif1 59-TGCGGTGCCCATGGA-39 59-CTGCCACGAACCCA-39 NM_053738.1
Primers used for qRT-PCR analysis of the genes assessed here, including the gene symbol, primer sequence (forward and reverse sequence respectively) and GenBank
accession number. The primers used to assess the expression of Wnt ligands and inhibitors not included in the list were obtained elsewhere [47].
doi:10.1371/journal.pone.0027000.t001
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of detection of the qRT-PCR protocol (Ct over 35). After injury,
the Wnt ligand mRNA expression was regulated distinctly at the
different time-points analyzed (Figure 1). The relative increases
and decreases observed with respect to the non-injured basal
value, allowed the ligands to be grouped in function of three
distinct patterns: i) no change or a slight reduction (Wnt7a and
10a); ii) early induction from 6 hours up to 3 dpi (Wnt1, 2a, 2b, 7b,
10b, 15, 16); and iii) late induction from 1–3 up to 7–14 dpi (Wnt4,
5a, 5b, 6, 9, 11). For instance, Wnt1 and 2 are good examples of
early induced genes that are markedly up-regulated up to 3 dpi,
after which their mRNA expression decreases to control levels by
7 dpi. Conversely, Wnt 5a, 5b and 6 exhibited a 50% reduction in
mRNA expression in the first 6 hpi, followed by a steady increase
from 1–3 dpi to 14 dpi, when maximal expression was observed
(Figure 1). Finally, none of the Wnt ligands with undetectable or
null levels in non-injured spinal cords were expressed following
injury.
Wnt inhibitors and modulators are differentially
expressed in the healthy and injured spinal cord
We next assessed the expression of secreted Wnt inhibitors and
modulators, key regulators of extracellular signalling by the large
and complex family of Wnt ligands. We focused our analysis on
the families with well described roles in the nervous system: Dkk-
1/4, sFRP-1/5 and Wif1. As observed for Wnt ligands, most of the
Wnt inhibitors and modulators were expressed in the non-injured
adult spinal cord, except sFRP-4 and sFRP-5 (Figure 2). Interest-
ingly, the specific inhibitors of the canonical pathway, Dkk-1/4,
were up-regulated early, with a striking peak of expression at
24 hpi that returned to basal levels at 3 dpi. The sFRPs are
generally considered as broad and non-specific Wnt inhibitors, yet
sFRP-1 and 2 exhibited a similar but slightly delayed pattern of
expression, with a narrow peak at 3 dpi, while sFRP-3 remained
stable. Finally, Wif1, a broad inhibitor of Wnt signalling, was
dramatically down-regulated from 24 hpi until the end of the
study.
Canonical Wnt signalling is active in the adult spinal cord
and in cells around the wound epicentre after SCI
At the cellular level, Wnt binding to Fz or non-conventional
receptors activates three distinct downstream signalling cascades:
the canonical or Wnt/b-catenin; and the non-canonical Planar
Cell Polarity (PCP, Wnt-JNK) and Wnt-Ca
2+ pathways. As the
non-canonical pathways remain poorly characterized, we focused
on a representative set of components in the main canonical
pathway. Irrespective of the Fz receptor expressed by a specific
cell, activation of the canonical pathway requires the expression
and recruitment (via serine phosphorylation) of LRP5/6 co-
receptors [10,50,51]. Importantly, both receptors were expressed
in non-injured adult spinal cord, a pattern which changed little for
mRNA after SCI (Figure 3). Moreover, active LRP6 was
homogenously distributed in the grey matter, although was also
observed in several cells around the wound epicentre at 24 hpi,
and it was even more prominent in the cells surrounding the cyst
and in the grey matter from 7 dpi (Figure 4). Dvl is thought to be a
key transducer of Wnt signalling [17] and it was expressed in a
similar pattern to LRP6, with an increase in the active
phosphorylated isoform 3 at 24 hpi peaking at 7 dpi (Figure 4).
Canonical activation relies on the dephosphorylation of b-
catenin by GSK-3ß and the eventual translocation of the active b-
catenin to the nucleus where it promotes transcription of a set of
target genes after interacting with members of the TCF/LEF
family [7,9]. b-catenin mRNA expression was up-regulated
following SCI, peaking at 6-24 hpi (a 1.8-fold increase when
compared to the controls) and returning to basal levels at 14 dpi.
In parallel, its negative regulator GSK-3b was also up-regulated at
6–24 hpi, its expression decreasing thereafter until the end of the
study (Figure 3). Strikingly, active b-catenin was expressed strongly
in the grey matter of the non-injured spinal cord with a highly
suggestive vascular pattern. SCI altered this pattern, with cells in
the white matter around the epicentre of the wound expressing b-
catenin, increasing in number and occupying the centre of the
wound at 7 dpi, and finally concentrating around the developing
cyst at 14–28 dpi (Figure 4).
Discussion
In the present study, we provide evidence that the expression of
Wnt ligands, their inhibitors and components of their intracellular
signalling pathways is prolonged in the adult spinal cord, as is the
activation of the canonical pathway, suggesting that the Wnt
family of proteins play a role in spinal cord function and
physiology. More importantly, in a clinically relevant rat model
of SCI we demonstrate that trauma induces a dramatic and time-
dependent change in the physiological pattern of Wnt mRNA
expression (Figure 5A). Furthermore, we describe a concomitant
activation of Dvl-3, the downstream intracellular signalling
transducer of Wnt, and activation of the canonical pathway in
cells around the wound core in a pattern suggesting that it
influences glial scar formation. To our knowledge, this is the first
report demonstrating constitutive expression of Wnts in the adult
spinal cord and their differential regulation after injury. These
observations are likely to be highly relevant to understanding the
potential role of Wnts in the cell and molecular responses induced
by SCI (Figure 5B).
The clinical outcome of SCI can be improved by limiting the
extent of secondary tissue damage, which is largely dependent on
the inflammatory response induced during both the acute and
chronic phases [2,3,52]. Minutes after injury, a massive inflam-
matory response is induced that is characterized by a variety of
complex and interrelated events and cellular responses, in
particular those involving astroglial and microglial reactivity or
leukocyte infiltration. It was recently suggested that canonical Wnt
signalling is involved in microglial proinflammatory instruction
[28], while inhibitory and inductive roles have also been proposed
for canonical and non-canonical signalling in proinflammation,
respectively [53–56]. Indeed, canonical activation by lithium,
Wnt1 or Wnt3a inhibits several inflammatory events, including
endothelial activation [57], transendothelial migration of mono-
cytes [58], and proinflammatory cytokine production by activated
macrophages [54,59]. By contrast, TLR/NFkB signalling pro-
motes the production of proinflammatory cytokines and Wnt5a in
an in vitro model of macrophage activation [53,55,56,60,61]. In
turn, these factors exert an autocrine effect through the Fz5-
mediated activation of the Wnt-Ca
2+ non-canonical pathway,
further augmenting the expression of pro-inflammatory genes.
Thus, Wnt5a has been proposed to be one of the key macrophage-
derived effector molecules that triggers and sustains chronic
inflammation through both autocrine and paracrine signalling.
Furthermore, the extent of the inflammatory response and that of
the secondary cell death appears to correlate with the disruption of
the blood spinal cord barrier (BSCB) [52,62,63], which may
require the activation of b-catenin in endothelial cells in order to
recover it the molecular and structural properties of a functionally
mature BSCB [64–67]. Interestingly, the physiological vascular-
like expression of active b-catenin protein was lost in the grey
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27000Figure 1. Wnt ligands expression in the spinal cord of adult rats following SCI. All Wnt ligands except for Wnt3, 3a, 8a and 8b were constitutively
expressed in the non-injured adult spinal cord. After SCI, 3 main patterns of Wnt ligand expression were observed: i) No change or slight reduction (Wnt7a and
10a); ii) early induction (Wnt1, 2a, 2b, 7b, 10b, 15 and 16); and iii) late induction (W n t 4 ,5 a ,5 b ,6 ,9and 11). All analyses were performed using total RNA samples
isolated from a 1 cm long fragment of the spinal cord from non-lesioned control animals (C) and fragments containing the wound from contused animals at
different times post-injury (6 and 24 hpi and 3, 7, 14 and 28 dpi). Expression of rat Wnt ligand genes was assessed by qRT-PCR using specific primers (Table 1
a n d[ 4 7 ] )a n dn o r m a l i z e dt or i b o s o m a l18S expression. Values for each experimental group and day are expressed as mean 6SEM, n=3. Each animal/sample
(‘‘n’’) was measured in triplicate in two occasions (2 independent technical triplicates, 6 measurements per sample). *p,0.05 compared with C.
doi:10.1371/journal.pone.0027000.g001
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27000Figure 2. Short term up-regulation of Wnt inhibitors expression after SCI. Expression of the Wnt inhibitor genes Dkk-1/4, sFRP (sFRP-1/5)
and Wif1 was quantified by qRT-PCR as described in Figure1. Expression of all the inhibitors except sFRP4 and 5 was detected in the non-injured
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expression of mRNA encoding canonical inhibitors like Dkk and
GSK-3b, and the later expression of Wnt5a mRNA, which was
previously shown to be expressed in reactive astrocytes of the glial
scar [33]. Wnt5a expression has also been reported in other cell
types, including fibroblasts [68] and endothelial cells [69],
suggesting a cross-talk between all the cells involved in restoring
tissue homeostasis after SCI, which based on our results may
involve a larger number of ligands, receptors, and modulators of
the Wnt family of proteins.
A serious consequence of SCI is the large-scale death of neurons
and oligodendrocytes due to excitotoxic and inflammatory
apoptosis [2,3]. In this regard, in different neuropathological
situations inhibition and activation of the canonical Wnt pathway
has been shown to induce neuronal death and survival, respec-
tively, including circumstances of excitotoxicity [23,25,70–72],
brain ischemia [25,43,73] and Parkinson’s [74] and Alzheimers
diseases [23,45,71,75–77]. Indeed, lithium is a non-specific GSK-
3ß inhibitor that is employed in the pharmacotherapy of bipolar
diseases and it is a potent inhibitor of apoptotic neuronal death in
vitro, as well as that associated with various neurodegenerative
conditions in vivo [73,78–81], including CNS stroke and SCI
[36,43]. This effect may be partly caused by the preservation and/
or reinduction of the barrier properties of brain microvessels in the
injured area. Importantly, acute administration of Wnt3a after
moderate SCI provokes a significant recovery of motor function in
association with a moderate neuroprotective effect [41]. Thus,
Wnts would appear to fulfil a role of in adult CNS physiology as
well as representing potential therapeutic targets.
Another critical impairment to functional recovery following
SCI is the generation of a glial scar around the epicentre of the
wound, which strongly inhibits axonal regeneration [3,4]. As
during development [6,82,83], Wnt proteins are critical factors
governing axonal growth after CNS injury. Both endogenous
Wnt2b and exogenous Wnt3a directly promote b-catenin-
dependent CNS regeneration in the retina of adult mammals
Figure 3. SCI alters the mRNA expression of canonical Wnt signalling components. Expression of the canonical co-receptor LRP5/6, the
downstream intracellular inhibitory transducer GSK3-ß and the ß-catenin transcription factor were quantified by qRT-PCR as described in Figure1. All
signalling components were expressed in non-injured spinal cord. SCI did not alter the transcription of the LRP5/6 co-receptors, although there was a
striking increase in GSK3-b expression that coincided with that of the Dkk inhibitors, as well as a mild up-regulation of b-catenin after 6 hours that
gradually decreased until the end of the study. Values for each experimental group and day are expressed as mean 6 SEM, n=3. Each animal/sample
(‘‘n’’) was measured in triplicate in two occasions (2 independent technical triplicates, 6 measurements per sample). *p,0.05 compared with non-
injured control animals (C).
doi:10.1371/journal.pone.0027000.g003
spinal cord. After SCI, the Dkks were strikingly up-regulated with a narrow and specific peak after 24 hours, followed by a slightly delayed peak at
3 dpi for sFRP-1 and 2. By contrast, Wif1 was dramatically down-regulated 24 hpi until the end of the study. Values for each experimental group and
day are expressed as mean 6 SEM, n=3. Each animal/sample (‘‘n’’) was measured in triplicate in two occasions (2 independent technical triplicates, 6
measurements per sample). *p,0.05 compared with non-injured control animals (C).
doi:10.1371/journal.pone.0027000.g002
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week after SCI improves locomotor recovery by promoting
axonal regeneration in rats [86]. Conversely, recent studies
reported that SCI-induced Wnt5a expression around the injury
site inhibited corticospinal axonal growth via non-canonical
activation of the Ryk receptor in both mice [32] and rats [33].
This effect was overcome by intrathecal administration of
Ryk neutralizing antibodies, enhancing the functional recovery.
Accordingly, GSK-3b inhibition by lithium increases the intrinsic
growth capacity of damaged neurons after SCI, permitting
significant sprouting of descending corticospinal and serotonin-
ergic axons in the caudal spinal cord and promoting functional
recovery [37,40]. On the other hand, glial scar is triggered by
BSCB disruption and microglia/macrophage activation [4].
Indeed, this process appears to correlate with the areas of
maximum BSCB breakdown and greatest number of activated
microglia/macrophages [87]. Therefore, we can not exclude that
at least in part Wnt promotion of axonal growth could be
mediated by indirect action on BSCB restoration and inflamma-
tory response modulation.
Wnts are also crucial physiological regulators of stem cells
[13,88,89], which is significant as the adult spinal cord has been
described to contain slow-dividing neural precursors that prolif-
erate and differentiate into NG2+ glial progenitors after SCI, and
they migrate around the lesion core to mainly form reactive
astrocytes [90,91]. b-catenin signalling is active in progenitor
populations from adult neurogenic regions like the hippocampus,
subventricular zone (SVZ) and olfactory bulb, and it is known to
participate in the injury response of various tissues, including the
CNS [26,35,84,92]. Indeed, b-catenin has been shown to be
responsible for SVZ/striatal proliferation after brain ischemia [93]
and to be transcriptionally active in NG2 precursors associated to
glial scar formation after traumatic brain injury [35]. However,
the same authors describe a total lack of b-catenin transcriptional
activation after SCI in mice, what could be derived of differences
between CNS regions in front of the same type of insult [35] and/
or versus to our results, a clear activation of both the canonical
LRP6 co-receptor and b-catenin in cells around the injury core in
a specific pattern that was highly suggestive of a role in glial scar
formation, the reflect of a distinct physiopathology in rats [94] or
intrinsic limitations of TCF-dependent transcriptional reporters
[95,96]. Intriguingly, a proportion of NG2+ positive precursors at
a distance from the wound epicentre can differentiate into Olig2+
oligodendroglial precursors (OPC). b-catenin induced transcrip-
tion is required for OPC instruction but following the inhibition
for differentiation into mature oligodendrocytes during develop-
ment and importantly adult remyelination [26,97,98]. Actually,
there is considerable interest in Wnts with regards the develop-
ment of novel stem cell based therapies [99], as Wnt3a increased
both exogenous [100] and endogenous [41] neuronal differenti-
ation of adult neural precursors.
In summary, our results provide compelling evidence that Wnts
are expressed and transcriptionally regulated by SCI in adulthood.
These novel findings provide an important foundation to further
address the function of individual Wnt proteins in vivo, by loss and
gain of function experiments, on the different cell populations of
the healthy and injured adult spinal cord. In support, evidence in
the literature already indicates that Wnts are not just mere
Figure 4. Active canonical Wnt signalling pathway in adult spinal cord before and after SCI. (A) Western blot of Dvl-3 with protein
samples isolated from a 1 cm long spinal cord fragment from non-lesioned control animals (C) and SCI animals at 1, 7 and 14/28 dpi. SCI induced
hyperphosphorylation (upper arrowhead) and thus, the activation of Dvl-3 24 hours post-injury, which peaked at 7 dpi. GAPDH levels were used as a
control for protein loading. (B) Representative histological images of the expression of the active LRP6 canonical co-receptor (phosphorylated at
serine 1490) and b-catenin (dephosphorylated at serine 37 and threonine 41) before SCI and at 1, 7 and 14/28 dpi. Active LRP6 and b-catenin were
both expressed in the grey matter of the non-injured spinal cord, the latter exhibiting a vascular-like pattern. After SCI, active LRP6 and b-catenin was
expressed in cells located in the white matter of the wound epicentre, with a clear increase from 7 dpi and a final location suggestive of a role in
tissue response. Scale bars=50 mm.
doi:10.1371/journal.pone.0027000.g004
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expressed by reactive astrocytes of the glial scar and play an
inhibitory role on corticospinal regeneration through non-
canonical Ryk activation [32,33], while lithium [36,43] or Wnt3a
[41] induced Wnt/b-catenin signalling exerts neuroprotective
effects in SCI. These findings, together with our data and
increasing evidence linking Wnt signalling with neurodegenerative
diseases in the adult [29] and in the development of CNS [6],
suggest that the Wnt family of proteins might play a role in the
pathophysiology of the SCI.
Figure 5. Temporal expression of Wnt mRNAs, and a schematic representation of Wnt signalling elements. (A) Summary of the
integrated mRNA expression for early (Wnt1, Wnt2a, Wnt2b) and late Wnt Ligands (Wnt4, Wnt5a/5b, Wnt6, Wnt7a, Wnt11), as well as the Wnt Canonical
Inhibitors (Dkk-1/4), sFRP (sFRP-1/3) and Wif1.( B) Representation of the Wnt/b-catenin and b-catenin-independent signalling pathways and their
putative roles in SCI.
doi:10.1371/journal.pone.0027000.g005
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